The nucleated cell count in CSF is a vital marker of immune system activity within the brain and spinal cord. Elevated levels often point to infection, inflammation, malignancy, or other CNS pathology, and always require interpretation in the context of other laboratory findings and clinical symptoms. A normal count generally suggests no active CNS inflammation or infection, but results must be considered alongside the patient’s overall clinical picture.

Nucleated Red Blood Cells (NRBCs) are immature red blood cells that have not yet expelled their nucleus. In a typical Complete Blood Count (CBC) test, the presence of NRBCs is significant and can provide valuable insights into a patient's health. While NRBCs are common in the bone marrow, where red blood cells are produced, they usually do not circulate in peripheral blood. Therefore, the appearance of NRBCs in a CBC test panel is noteworthy and often indicates an abnormality or a stress response within the body.

The percentage of NRBCs in blood can be crucial for diagnosing various conditions. Normally, these cells are filtered out of the bloodstream as they mature in the bone marrow, so their presence in a CBC indicates that the bone marrow is releasing cells into the bloodstream prematurely. This can occur due to several reasons, such as severe anemia, hypoxia, bone marrow disorders, or other conditions that disrupt normal red blood cell production. In such cases, the bone marrow may be overactive or under stress, leading to the premature release of these immature cells.

NRBCs (Nucleated Red Blood Cells) are immature red blood cells that still contain a nucleus. In healthy adults and children older than approximately one week, NRBCs are not present in circulating blood — they are confined to the bone marrow where red blood cells mature. A result of 0.0, or a notation like "< 0.20 × 10⁹/L [0.0–0.2]," is normal and expected. When NRBCs appear in peripheral blood above the upper limit of normal (typically above 0.02 × 10⁹/L or above 0/100 WBC), it signals that the bone marrow is releasing immature cells under stress — most commonly from severe anemia, severe hypoxia, or bone marrow pathology.

The Oat marker measures IgG antibodies to proteins found in oats. Results are reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a diagnosis of celiac disease or oat allergy. Interpretation should consider digestive symptoms, gluten exposure, and overall dietary patterns.

The presence of antibodies to Oats is an indication of food immune reactivity. The offending food and its known cross-reactive foods should be eliminated from the diet. Adverse reactions to Oat have been reported. Genetically speaking, Oats do not contain gluten and thereby should be safe to eat for the celiac or non-celiac gluten-sensitive patient. However, due to cross-contamination of Oats during transportation and food processing, they may become harmful to the gluten-reactive population. Some varieties of Oats have been shown to cross-react with gliadin.

The Occludin IgG1-4+C3d test on a gut barrier panel detects immune responses against occludin, a key protein in gut lining integrity. Positive results indicate autoimmune reactions, potentially leading to "leaky gut" and related gastrointestinal issues. A negative result suggests a healthy gut barrier. This test is vital for assessing and managing gut health conditions.

Occludin and Zonulin are proteins of the tight junctions found between epithelial cells of the intestinal barrier. These proteins are gate keepers of the body, allowing only small amino acid nutrients to pass into the blood stream.

Occludin and Zonulin are proteins of the tight junctions found between epithelial cells of the intestinal barrier. These proteins are gate keepers of the body, allowing only small amino acid nutrients to pass into the blood stream. When tight junction proteins are functioning properly, they prevent large molecules from crossing the intestinal barrier into the blood stream, where they can elicit an immune response.

Occludin and Zonulin are proteins of the tight junctions found between epithelial cells of the intestinal barrier. These proteins are gate keepers of the body, allowing only small amino acid nutrients to pass into the blood stream.

Occludin and Zonulin are proteins of the tight junctions found between epithelial cells of the intestinal barrier. These proteins are gate keepers of the body, allowing only small amino acid nutrients to pass into the blood stream.

In many cases, a positive occult blood results from gastrointestinal bleeding from the upper small intestine or higher. Gastric ulceration could, for example, result in a finding of occult blood rather than blood in the feces. However, a positive finding of occult blood may also be associated with colon cancer, ulcerative colitis (check fecal calprotectin and lactoferrin levels), ulceration of the esophagus, stomach or duodenum, diverticulitis, and gastric carcinoma.

The fecal occult blood test (=FOBT) looks for blood in your feces. “Occult” (=hidden) means that the blood amount is so small that it cannot be seen with the naked eye. The bleeding does not change the color of the stool or result in visible bright red blood. Therefore, the blood is found only by testing the stool for blood in the laboratory.

Fecal Immunochemical Test (FIT) – Stool Occult Blood

The fecal immunochemical test (FIT) checks for hidden blood in stool using antibodies specific to human hemoglobin. This makes it more accurate for detecting bleeding from the colon or rectum than older guaiac-based stool tests, and unlike those tests, FIT does not require dietary restrictions.

Blood in stool can result from polyps, colorectal cancer, hemorrhoids, inflammation, or other lower GI conditions. Detecting blood early is important, since finding and removing polyps may help prevent colorectal cancer. For people at average risk, FIT is often recommended once a year beginning at age 45.

How to collect: Use the provided kit exactly as instructed—usually swiping a brush or applicator across the stool surface, sealing it in the collection tube, and returning it promptly. Try to avoid collecting during menstruation or with heavy hemorrhoid bleeding.

Interpreting results:

• Negative: No blood found. This is reassuring, but regular screening is still needed, since some problems bleed intermittently.

• Positive: Blood was detected. This does not necessarily mean cancer but usually leads to a follow-up colonoscopy to find the cause.

• Invalid: The sample could not be tested correctly and should be repeated.

While a positive result may be caused by polyps, hemorrhoids, fissures, or inflammation, it should always be followed up. A negative test lowers the chance of bleeding from the colon, but continued annual testing is important.